| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Merus N.V (NASDAQ: MRUS)
MRUS Technical Analysis
4
| As on 9th Jun 2023 MRUS STOCK Price closed @ 23.60 and we RECOMMEND Sell for LONG-TERM with Stoploss of 23.63 & Strong Sell for SHORT-TERM with Stoploss of 27.69 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MRUSSTOCK Price
| Open | 23.29 | Change | Price | % |
| High | 23.78 | 1 Day | 0.31 | 1.33 |
| Low | 22.82 | 1 Week | 2.88 | 13.90 |
| Close | 23.60 | 1 Month | 3.41 | 16.89 |
| Volume | 429495 | 1 Year | -6.69 | -22.09 |
| 52 Week High 32.29 | 52 Week Low 12.80 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| MRUS Daily Charts |
MRUS Intraday Charts |
Whats New @ Bazaartrend |
MRUS Free Analysis |
|
|
MRUS Important Levels Intraday
| RESISTANCE | 25.45 |
| RESISTANCE | 24.86 |
| RESISTANCE | 24.49 |
| RESISTANCE | 24.12 |
| SUPPORT | 23.08 |
| SUPPORT | 22.71 |
| SUPPORT | 22.34 |
| SUPPORT | 21.75 |
MRUS Forecast May 2024
| 4th UP Forecast | 39.42 |
| 3rd UP Forecast | 34.35 |
| 2nd UP Forecast | 31.21 |
| 1st UP Forecast | 28.07 |
| 1st DOWN Forecast | 19.13 |
| 2nd DOWN Forecast | 15.99 |
| 3rd DOWN Forecast | 12.85 |
| 4th DOWN Forecast | 7.78 |
MRUS Weekly Forecast
| 4th UP Forecast | 29.25 |
| 3rd UP Forecast | 27.44 |
| 2nd UP Forecast | 26.32 |
| 1st UP Forecast | 25.20 |
| 1st DOWN Forecast | 22.00 |
| 2nd DOWN Forecast | 20.88 |
| 3rd DOWN Forecast | 19.76 |
| 4th DOWN Forecast | 17.95 |
MRUS Forecast2024
| 4th UP Forecast | 64.14 |
| 3rd UP Forecast | 51.14 |
| 2nd UP Forecast | 43.1 |
| 1st UP Forecast | 35.07 |
| 1st DOWN Forecast | 12.13 |
| 2nd DOWN Forecast | 4.1 |
| 3rd DOWN Forecast | -3.94 |
| 4th DOWN Forecast | -16.94 |
Merus N.V ( NASDAQ USA Symbol : MRUS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MRUS Business Profile
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trial for the treatment of patients with metastatic breast cancer, as well as in Phase 1/2 for the pancreatic and lung cancer, and other solid tumors. The company is also developing MCLA-117 that is in phase I clinical trial for the treatment of patients with acute myeloid leukemia; MCLA-158, which is in a phase I clinical trial for the treatment of solid tumors; and ONO-4685 that is Phase 1 clinical trial to treat autoimmune disease. In addition, its research and development stage bispecific antibody candidates include MCLA-129, which is being developed in collaboration with Betta Pharmaceuticals Co. Ltd; MCLA-145, which is being developed in collaboration with Incyte Corporation; and clinical programs to explore potential combination therapies or indication. Merus N.V. has collaborations and license agreement with Loxo Oncology at Lilly to discover and research novel T-cell re-directing bispecific antibodies. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands. Address: Yalelaan 62, Utrecht, Netherlands, 3584 CM
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service